However, the dose reduction was greater with DeliDose than with CliDose in terms of V40 Gy (DeliDose: 61.2%, CliDose: 65.1% for Eclipse) and V50 Gy (DeliDose: 7.4%, CliDose: 11.0%) for the rectum, although the difference did not reach statistical significance.
← all excerpts
Evaluation of deliverable artificial intelligence-based automated volumetric arc radiation therapy planning for whole pelvic radiation in gynecologic cancer.
1
—
—